Recursion Pharmaceuticals, Inc. RXRX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease right-of-use assets in other assets of $42.82M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets decreased by 19.5% year-over-year, from $53.19M to $42.82M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets has grown at a 8.3% compound annual growth rate (CAGR), from $32.9M to $45.34M.